Mark J. Guinan's Insider Trades & SAST Disclosures
Mark J. Guinan's most recent trade in UpHealth Inc was a trade of 100,000 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark J. Guinan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UpHealth Inc | Guinan J. Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 100,000 | 160,606 | - | 0 | Common Stock | |
| UpHealth Inc | Mark J. Guinan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 60,606 | 60,606 | - | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 20,780 | 109,456 (0%) | 0% | 130.1 | 2,703,270 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 10,475 | 98,981 (0%) | 0% | 130.1 | 1,362,693 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 10,932 | 10,932 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,251 | 88,676 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 1,673 | 87,119 (0%) | 0% | 130.1 | 217,641 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 694 | 86,425 (0%) | 0% | 130.2 | 90,380 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 115.42 per share. | 09 Mar 2021 | 17,322 | 95,195 (0%) | 0% | 115.4 | 1,999,305 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.42 per share. | 09 Mar 2021 | 6,403 | 88,792 (0%) | 0% | 115.4 | 739,034 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.15 per share. | 23 Feb 2021 | 830 | 78,414 (0%) | 0% | 121.2 | 100,555 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.19 per share. | 23 Feb 2021 | 541 | 77,873 (0%) | 0% | 121.2 | 65,564 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 31,774 | 31,774 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 5,665 | 79,244 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.51 per share. | 24 Dec 2020 | 81,756 | 155,335 (0%) | 0% | 66.5 | 5,437,592 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2020 | 81,756 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 120.06 per share. | 24 Dec 2020 | 59,193 | 96,142 (0%) | 0% | 120.1 | 7,106,534 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 121.18 per share. | 24 Dec 2020 | 22,563 | 73,579 (0%) | 0% | 121.2 | 2,734,139 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.17 per share. | 08 Jun 2020 | 72,596 | 146,175 (0%) | 0% | 71.2 | 5,166,657 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 72,596 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 116.81 per share. | 08 Jun 2020 | 45,826 | 100,349 (0%) | 0% | 116.8 | 5,352,981 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 117.65 per share. | 08 Jun 2020 | 18,246 | 82,103 (0%) | 0% | 117.6 | 2,146,624 | Common Stock |
| Quest Diagnostics, Inc. | Mark J. Guinan | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 118.60 per share. | 08 Jun 2020 | 8,524 | 73,579 (0%) | 0% | 118.6 | 1,010,980 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges